Streetinsider.com Pre-Open Movers 07/19: (OXGN) (ASTX) (SWKS) Higher; (ISRG) (MSFT) (CYH) Lower (more...) Jul 19, 2013 09:33AM
Notable Analyst Rating Changes 10/25: (AKAM) (SWKS) (FTI) Upgraded; (NYB) (FFIV) (HEK) Downgraded Oct 25, 2012 11:13AM
Needham & Company Downgrades Progenics Pharmaceuticals (PGNX) to Hold; Concerns on Lack of Clarity with Relistor Jul 30, 2012 10:15AM
Needham & Company Raises Estimates on Cubist Pharmaceuticals (CBST); Modestly Above Expectations Jul 20, 2012 07:54AM
Needham & Company Q2 Preview on Cubist Pharmaceuticals (CBST); Cubicin Sales Estimate is $195M Jul 18, 2012 10:50AM


Jun 12, 2012 07:47AM Needham & Company Maintains a 'Hold' on Cubist Pharmaceuticals (CBST); Review of Investor Day
May 11, 2012 08:18AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Dificid Hits Sales Goal under Cubist Collaboration
Apr 19, 2012 07:36AM Needham & Company maintains a 'Hold' on Cubist Pharmaceuticals (CBST); Cubicin Sales Beat; Awaiting Progression
Jan 20, 2012 10:47AM Needham & Company Maintains a 'Hold' on Cubist Pharmaceuticals (CBST); 4Q11 Review. U.S. Cubicin Sales Guidance for 2012 In-line with Our Expectations
Dec 23, 2011 07:35AM Needham & Company 2012 Biotech Preview
Oct 20, 2011 07:28AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); 3Q11 U.S. Cubicin Sales Well Above Expectations
Sep 29, 2011 01:15PM Needham & Company Reiterates 'Buy' on Optimer Pharmaceuticals (OPTR); Collaborator/Competitor Cubist Confirms Plans to Bring CB-315 into Phase 3
Sep 22, 2011 02:13PM Needham & Company Maintains a 'Buy' on Cubist Pharmaceuticals (CBST); Favorably Inclined Towards the Stock
Jul 15, 2011 07:52AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); 2Q11 Cubicin Sales Slightly Above Expectations and Guidance Raised for the Year
Apr 15, 2011 08:07AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); U.S. and International Cubicin Sales Beat Expectations
Apr 5, 2011 09:10AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); Teva and Cubist Settle Cubicin Litigation
Jan 21, 2011 08:31AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); '11 Cubicin Guidance Modestly Lower than Anticipated; Litigation is Principal Driver of Stock
Sep 21, 2010 07:58AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); Analyst Day Review
Jul 16, 2010 08:40AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); 2Q10 Review. Cubicin Sales and EPS Beat Estimates
Apr 16, 2010 09:59AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); Focused on Upcoming Pipeline News
Apr 1, 2010 11:15AM Needham & Company Maintains Bullish Stance on Cubist Pharmaceuticals (CBST) Despite CB-929 Termination
Jan 23, 2009 11:06AM Needham & Co Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST)
Oct 17, 2008 09:18AM Needham & Co Reiterates a 'Buy' Rating on Cubist Pharmaceuticals (CBST), Raises Earnings Estimates and Price Target
Jul 1, 2008 08:51AM Needham Starts Cubist Pharmaceuticals (CBST) at Buy